Oncurious NV Announces FDA Acceptance of Investigational New Drug (IND) Application for a Phase I/IIa Study with TB-403 for the Treatment of Pediatric Brain Tumors

(Source: Clinical Trials And Noteworthy Treatments For Brain Tumors)

from #Medicine-Sfakianakis via simeraentaxei on Inoreader http://ift.tt/1nrjJJ4
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/1RtAjEC
via IFTTT